The findings were presented Wednesday, Oct. 14, during TCT Connect 2020.
The authors reviewed 23 different clinical trials—and more than 13,000 unique patients—for their research.
The findings were presented Thursday, Oct. 15, at TCT Connect 2020.
Researchers developed and implemented a four-step process for identifying patients who can be discharged early following PCI.
The transplant, performed at UC San Diego Health, was part of an ongoing clinical trial.
One key detail is that no stent thrombosis events were reported among the study's 201 participants.
There was a 33% increase in a patient’s hazard for mortality if they received care at a community hospital.
Innovate Healthcare thanks our partners for supporting our newsletters.Sponsorship has no influence on editorial content.Interested in reaching our audiences, contact our team*|LIST:ADDRESSLINE|*You received this email because you signed up for newsletters from Innovate Healthcare.Change your preferences or unsubscribe hereContact Us | Unsubscribe from all | Privacy Policy© Innovate Healthcare, a TriMed Media brand
